+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diabetes Injection Pens Market - Global Forecast to 2030- Product Image
Diabetes Injection Pens Market - Global Forecast to 2030- Product Image
Sale

Diabetes Injection Pens Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989869
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Diabetes Injection Pens Market grew from USD 17.46 billion in 2024 to USD 18.50 billion in 2025. It is expected to continue growing at a CAGR of 5.90%, reaching USD 24.63 billion by 2030.

The global field of pen-based diabetes therapy stands at a pivotal juncture. As insulin delivery systems evolve, stakeholders from device engineers to healthcare providers are witnessing rapid innovation driven by patient-centric needs, technological advancements, and shifting regulatory landscapes. Injection pens now offer features once unimaginable: digital dose tracking, ergonomic designs tailored for arthritic and visually impaired users, memory functions to reduce dosage errors, and seamless connectivity with mobile applications. These developments have elevated pens from mere delivery tools to comprehensive diabetes management platforms.

Looking ahead, the market will hinge on adaptability. Manufacturers must navigate trade policy changes, diversify regional supply chains, and address emerging patient demographics-from newly diagnosed pediatric populations to a growing cohort of senior citizens requiring long-term management. This introduction lays the foundation for an in-depth exploration of the transformative forces, tariff implications, segmentation breakthroughs, and strategic imperatives shaping the next chapter in diabetes injection pens.

Transformative Shifts Redefining Injectable Diabetes Management

Over the past decade, several paradigm shifts have redefined injectable diabetes care. The rise of digital assistance has transformed conventional pens into smart devices capable of logging doses and integrating with health apps. Simultaneously, ergonomic design enhancements such as grippable structures and soft-click buttons have improved accessibility for those with limited dexterity. Regulatory emphasis on patient safety has accelerated approvals for pens featuring audible clicks and large print, catering to visually impaired users.

Moreover, an industry-wide pivot toward patient personalization is manifesting in a wider array of insulin types, from rapid-acting analog formulations to pre-mixed preparations for simplified dosing. Health systems are increasingly adopting variable-dose disposable pens in home care, while specialized centers prioritize reusable pens with memory functions to reduce medical errors. As investors weigh domestic manufacturing against import tariffs, supply chain resilience and local production capacity have become strategic differentiators.

Cumulative Impact of United States Tariffs 2025 on Market Dynamics

With the introduction of new United States tariffs in 2025 targeting select medical device components, cost structures for pen-based insulin delivery are under pressure. Imported plastic housings and electronic modules now attract higher duties, directly impacting prices for fixed-dose disposable pens and reusable models equipped with Bluetooth connectivity. Manufacturers reliant on overseas suppliers must either absorb these expenses-squeezing margins-or pass them on to healthcare providers and patients.

In response, global players are reshoring key production steps. Some companies are forging alliances with domestic electronics firms to localize memory-chip assembly, while others negotiate tariff exclusions for essential raw materials. Concurrently, health systems evaluate alternative procurement channels to mitigate price hikes. Although short-term supply disruptions may arise, these adjustments are poised to spur long-term innovation in domestic manufacturing and strengthen supply chain agility.

Key Segmentation Insights Unveiling Market Opportunities

A multifaceted segmentation approach reveals distinct growth pathways. Analyzing usage patterns shows that home care personal use continues to expand, fueled by fixed-dose disposable pens that simplify self-management, while hospitals-ranging from diabetes care centers to multispecialty facilities-are standardizing on reusable pens with memory function to optimize clinical workflows. Within Type Of Injection Pen, fixed-dose and variable-dose disposables dominate retail settings, whereas defined memory features underpin uptake of reusable models in institutional environments.

Modes Of Delivery further differentiate market demand. Long-acting basal delivery pens address overnight glucose control for senior citizens and long-term Type 1 management, while rapid-acting and short-acting bolus pens remain essential for pediatric adolescents and newly diagnosed patients requiring flexible dosing. Pre-mixed insulin options cater to young adults and those initiating Type 2 insulin therapy. In therapeutic brands, Lispro-based pens such as Humalog Kwikpen lead among middle-aged adults, Detemir-based Levemir Flexpen maintains strength in geriatric cohorts, and Aspart-based Novolog Flexpen attracts tech-savvy patients seeking app integration.

Patient demographics shape tailored product strategies. Young adults embrace Bluetooth-enabled devices, whereas senior citizens prefer non-slip designs and large-print indicators. Ergonomic grippable structures serve arthritis sufferers, and audible clicks benefit visually impaired users. Between insulin classes, long-acting analog formulations outpace NPH in chronic management, while rapid-acting analogs remain the standard for mealtime dosing. End users split between Type 1 populations managing long-term therapy and Type 2 patients adjusting medication or initiating insulin, underscoring the need for adaptable pen portfolios.

Regional Dynamics Shaping Global Pen Distribution

Regional nuances shape the competitive landscape. In the Americas, advanced healthcare infrastructure and insurance frameworks accelerate adoption of smart pens with app integration, driving demand for feature-rich devices. Meanwhile, Europe, Middle East & Africa witness growing emphasis on regulatory harmonization and value-based procurement, prompting suppliers to demonstrate cost-effectiveness alongside clinical benefits. In Asia-Pacific, rising diabetes prevalence in emerging economies spurs volume growth, with price-sensitive markets favoring non-slip ergonomic designs and reusable pens supported by local manufacturing initiatives.

Cross-regional collaboration is gaining momentum: partnerships between Western technology leaders and Asia-Pacific contract manufacturers are streamlining production and reducing lead times. Simultaneously, tailored reimbursement policies in EMEA encourage inclusion of memory functions and Bluetooth connectivity in national formularies, illustrating the interplay between regulatory environments and device innovation.

Competitive Landscape and Leading Industry Players

Leadership in this space hinges on strategic collaborations, product differentiation, and operational excellence. AstraZeneca PLC leverages its biologics expertise to co-develop digital pens, while Becton, Dickinson, and Company invests in ergonomic designs for arthritis sufferers. Biocon Limited focuses on cost-effective analog insulin pens tailored for emerging markets, and Dexcom Inc. integrates continuous glucose monitoring data with smart pen platforms.

Eli Lilly and Company and Sanofi S.A. reinforce their market positions through new pen configurations for rapid-acting analogs and pre-mixed formulations. F. Hoffmann-La Roche AG and Novartis AG explore AI-driven dosing algorithms, collaborating with Haselmeier GmbH and Owen Mumford Limited to enhance device usability. Jiangsu Delfu Medical Device Co., Ltd. and Ypsomed Holding AG expand regional manufacturing, while Medtronic PLC and Novo Nordisk A/S pioneer app integration and memory-enabled reusable pens. Merck KGaA and Pfizer Inc. pursue targeted label extensions to cover pediatric and geriatric segments, demonstrating the breadth of approaches within the competitive field.

Actionable Recommendations for Industry Leaders to Drive Growth

To secure a leading position, industry stakeholders should prioritize the following strategies. First, accelerate integration of digital assistance features-such as Bluetooth connectivity and app integration-into both disposable and reusable pens to enhance patient engagement and real-time monitoring. Second, optimize manufacturing footprints by establishing modular production lines in tariff-sensitive regions, thereby minimizing duty impact and improving supply chain resilience.

Third, develop targeted product variants with ergonomic enhancements-grippable structures, soft-click buttons, and large-print indicators-to address the specific needs of arthritis sufferers and visually impaired users. Fourth, forge cross-sector partnerships to refine dosing algorithms, leveraging continuous glucose data from monitoring devices to inform dose recommendations within the pen platform. Fifth, engage with regional regulators and payers early to secure formulary inclusion for pens featuring memory functions and pre-mixed insulin, ensuring broad access across diverse healthcare systems.

Conclusion: Steering Future Success in Pen-Based Diabetes Care

The journey ahead will demand agility, collaboration, and patient-centric innovation. By aligning product roadmaps with evolving patient expectations-embracing digital connectivity, tailored ergonomics, and intelligent dosing-manufacturers can capture new segments while reinforcing their competitive edge. Strategic localization of manufacturing and proactive engagement with regulators will mitigate tariff and reimbursement challenges, safeguarding both margins and market access.

Ultimately, the most successful organizations will transcend the role of device suppliers to become comprehensive diabetes care partners, offering integrated solutions that blend hardware, software, and data analytics. This holistic approach will elevate patient outcomes, foster stronger provider relationships, and unlock sustainable growth in the dynamic field of pen-based insulin delivery.

Market Segmentation & Coverage

This research report categorizes the Diabetes Injection Pens Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Home Care
    • Personal Use
  • Hospitals
    • Diabetes Care Centers
    • General Hospitals
    • Multispecialty Hospitals
  • Disposable Pens
    • Fixed-Dose Pens
    • Variable-Dose Pens
  • Reusable Pens
    • With Memory Function
    • Without Memory Function
  • Basal Delivery
    • Long-Acting Insulin
  • Bolus Delivery
    • Rapid-Acting Insulin
    • Short-Acting Insulin
  • Mixed Delivery
    • Pre-Mixed Insulin
  • Humalog Kwikpen
    • Lispro Insulin
  • Levemir Flexpen
    • Detemir Insulin
  • Novolog Flexpen
    • Aspart Insulin
  • Adult Patients
    • Middle-Aged Adults
    • Young Adults
  • Geriatric Patients
    • Senior Citizens
  • Pediatric Patients
    • Adolescents
    • Infants to Toddlers
  • Digital Assistance
    • App Integration
    • Bluetooth Connectivity
  • Ergonomic Design
    • Grippable Structure
    • Non-Slip Design
  • Arthritis Suffers
    • Easy-Twist Mechanism
    • Soft-Click Button
  • Visually Impaired Users
    • Audible Clicks
    • Large Print On Pens
  • Analog Insulin
    • Long-Acting Analog
    • Rapid-Acting Analog
  • Human Insulin
    • NPH
    • Regular
  • Type 1 Diabetes Patients
    • Long-Term Management
    • Newly Diagnosed
  • Type 2 Diabetes Patients
    • Insulin Therapy Initiation
    • Medication Adjustments

This research report categorizes the Diabetes Injection Pens Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Diabetes Injection Pens Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AstraZeneca PLC
  • Becton, Dickinson, and Company
  • Biocon Limited
  • Dexcom Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Haselmeier GmbH
  • Jiangsu Delfu Medical Device Co., Ltd.
  • Medtronic PLC
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Owen Mumford Limited
  • Pfizer Inc.
  • Sanofi S.A.
  • Ypsomed Holding AG

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Diabetes Injection Pens Market, by Usage
8.1. Introduction
8.2. Home Care
8.2.1. Personal Use
8.3. Hospitals
8.3.1. Diabetes Care Centers
8.3.2. General Hospitals
8.3.3. Multispecialty Hospitals
9. Diabetes Injection Pens Market, by Type Of Injection Pen
9.1. Introduction
9.2. Disposable Pens
9.2.1. Fixed-Dose Pens
9.2.2. Variable-Dose Pens
9.3. Reusable Pens
9.3.1. With Memory Function
9.3.2. Without Memory Function
10. Diabetes Injection Pens Market, by Modes Of Delivery
10.1. Introduction
10.2. Basal Delivery
10.2.1. Long-Acting Insulin
10.3. Bolus Delivery
10.3.1. Rapid-Acting Insulin
10.3.2. Short-Acting Insulin
10.4. Mixed Delivery
10.4.1. Pre-Mixed Insulin
11. Diabetes Injection Pens Market, by Therapeutic Product Brands
11.1. Introduction
11.2. Humalog Kwikpen
11.2.1. Lispro Insulin
11.3. Levemir Flexpen
11.3.1. Detemir Insulin
11.4. Novolog Flexpen
11.4.1. Aspart Insulin
12. Diabetes Injection Pens Market, by Patient Demographics
12.1. Introduction
12.2. Adult Patients
12.2.1. Middle-Aged Adults
12.2.2. Young Adults
12.3. Geriatric Patients
12.3.1. Senior Citizens
12.4. Pediatric Patients
12.4.1. Adolescents
12.4.2. Infants to Toddlers
13. Diabetes Injection Pens Market, by Prominent Features
13.1. Introduction
13.2. Digital Assistance
13.2.1. App Integration
13.2.2. Bluetooth Connectivity
13.3. Ergonomic Design
13.3.1. Grippable Structure
13.3.2. Non-Slip Design
14. Diabetes Injection Pens Market, by User Accessibility
14.1. Introduction
14.2. Arthritis Suffers
14.2.1. Easy-Twist Mechanism
14.2.2. Soft-Click Button
14.3. Visually Impaired Users
14.3.1. Audible Clicks
14.3.2. Large Print On Pens
15. Diabetes Injection Pens Market, by Insulin Types
15.1. Introduction
15.2. Analog Insulin
15.2.1. Long-Acting Analog
15.2.2. Rapid-Acting Analog
15.3. Human Insulin
15.3.1. NPH
15.3.2. Regular
16. Diabetes Injection Pens Market, by End Users
16.1. Introduction
16.2. Type 1 Diabetes Patients
16.2.1. Long-Term Management
16.2.2. Newly Diagnosed
16.3. Type 2 Diabetes Patients
16.3.1. Insulin Therapy Initiation
16.3.2. Medication Adjustments
17. Americas Diabetes Injection Pens Market
17.1. Introduction
17.2. Argentina
17.3. Brazil
17.4. Canada
17.5. Mexico
17.6. United States
18. Asia-Pacific Diabetes Injection Pens Market
18.1. Introduction
18.2. Australia
18.3. China
18.4. India
18.5. Indonesia
18.6. Japan
18.7. Malaysia
18.8. Philippines
18.9. Singapore
18.10. South Korea
18.11. Taiwan
18.12. Thailand
18.13. Vietnam
19. Europe, Middle East & Africa Diabetes Injection Pens Market
19.1. Introduction
19.2. Denmark
19.3. Egypt
19.4. Finland
19.5. France
19.6. Germany
19.7. Israel
19.8. Italy
19.9. Netherlands
19.10. Nigeria
19.11. Norway
19.12. Poland
19.13. Qatar
19.14. Russia
19.15. Saudi Arabia
19.16. South Africa
19.17. Spain
19.18. Sweden
19.19. Switzerland
19.20. Turkey
19.21. United Arab Emirates
19.22. United Kingdom
20. Competitive Landscape
20.1. Market Share Analysis, 2024
20.2. FPNV Positioning Matrix, 2024
20.3. Competitive Analysis
20.3.1. AstraZeneca PLC
20.3.2. Becton, Dickinson, and Company
20.3.3. Biocon Limited
20.3.4. Dexcom Inc.
20.3.5. Eli Lilly and Company
20.3.6. F. Hoffmann-La Roche AG
20.3.7. Haselmeier GmbH
20.3.8. Jiangsu Delfu Medical Device Co., Ltd.
20.3.9. Medtronic PLC
20.3.10. Merck KGaA
20.3.11. Novartis AG
20.3.12. Novo Nordisk A/S
20.3.13. Owen Mumford Limited
20.3.14. Pfizer Inc.
20.3.15. Sanofi S.A.
20.3.16. Ypsomed Holding AG
21. ResearchAI
22. ResearchStatistics
23. ResearchContacts
24. ResearchArticles
25. Appendix
List of Figures
FIGURE 1. DIABETES INJECTION PENS MARKET MULTI-CURRENCY
FIGURE 2. DIABETES INJECTION PENS MARKET MULTI-LANGUAGE
FIGURE 3. DIABETES INJECTION PENS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY TYPE OF INJECTION PEN, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY TYPE OF INJECTION PEN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY MODES OF DELIVERY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY MODES OF DELIVERY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY THERAPEUTIC PRODUCT BRANDS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY THERAPEUTIC PRODUCT BRANDS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PROMINENT FEATURES, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PROMINENT FEATURES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USER ACCESSIBILITY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USER ACCESSIBILITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN TYPES, 2024 VS 2030 (%)
FIGURE 22. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 24. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 28. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. DIABETES INJECTION PENS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 34. DIABETES INJECTION PENS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DIABETES INJECTION PENS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PERSONAL USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY MULTISPECIALTY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY TYPE OF INJECTION PEN, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY FIXED-DOSE PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY VARIABLE-DOSE PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE PENS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY WITH MEMORY FUNCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY WITHOUT MEMORY FUNCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE PENS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY MODES OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY BASAL DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY LONG-ACTING INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY BASAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY BOLUS DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY RAPID-ACTING INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY SHORT-ACTING INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY BOLUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY MIXED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRE-MIXED INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY MIXED DELIVERY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY THERAPEUTIC PRODUCT BRANDS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HUMALOG KWIKPEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY LISPRO INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HUMALOG KWIKPEN, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY LEVEMIR FLEXPEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DETEMIR INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY LEVEMIR FLEXPEN, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY NOVOLOG FLEXPEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ASPART INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY NOVOLOG FLEXPEN, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY MIDDLE-AGED ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY GERIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY SENIOR CITIZENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INFANTS TO TODDLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PROMINENT FEATURES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DIGITAL ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY APP INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY BLUETOOTH CONNECTIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DIGITAL ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ERGONOMIC DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY GRIPPABLE STRUCTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY NON-SLIP DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ERGONOMIC DESIGN, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USER ACCESSIBILITY, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ARTHRITIS SUFFERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY EASY-TWIST MECHANISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY SOFT-CLICK BUTTON, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ARTHRITIS SUFFERS, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY VISUALLY IMPAIRED USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY AUDIBLE CLICKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY LARGE PRINT ON PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY VISUALLY IMPAIRED USERS, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN TYPES, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ANALOG INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY LONG-ACTING ANALOG, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY RAPID-ACTING ANALOG, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ANALOG INSULIN, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HUMAN INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY NPH, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HUMAN INSULIN, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY TYPE 1 DIABETES PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY LONG-TERM MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY NEWLY DIAGNOSED, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY TYPE 1 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY TYPE 2 DIABETES PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN THERAPY INITIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY MEDICATION ADJUSTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY TYPE 2 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY TYPE OF INJECTION PEN, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE PENS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE PENS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY MODES OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY BASAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY BOLUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY MIXED DELIVERY, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY THERAPEUTIC PRODUCT BRANDS, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY HUMALOG KWIKPEN, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY LEVEMIR FLEXPEN, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY NOVOLOG FLEXPEN, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY PROMINENT FEATURES, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY DIGITAL ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY ERGONOMIC DESIGN, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY USER ACCESSIBILITY, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY ARTHRITIS SUFFERS, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY VISUALLY IMPAIRED USERS, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY INSULIN TYPES, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY ANALOG INSULIN, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY HUMAN INSULIN, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY TYPE 1 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY TYPE 2 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY TYPE OF INJECTION PEN, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE PENS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE PENS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY MODES OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY BASAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY BOLUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY MIXED DELIVERY, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY THERAPEUTIC PRODUCT BRANDS, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY HUMALOG KWIKPEN, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY LEVEMIR FLEXPEN, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY NOVOLOG FLEXPEN, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY PROMINENT FEATURES, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY DIGITAL ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY ERGONOMIC DESIGN, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY USER ACCESSIBILITY, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY ARTHRITIS SUFFERS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY VISUALLY IMPAIRED USERS, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY INSULIN TYPES, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY ANALOG INSULIN, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY HUMAN INSULIN, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY TYPE 1 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY TYPE 2 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY TYPE OF INJECTION PEN, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE PENS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE PENS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY MODES OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY BASAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY BOLUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY MIXED DELIVERY, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY THERAPEUTIC PRODUCT BRANDS, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY HUMALOG KWIKPEN, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY LEVEMIR FLEXPEN, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY NOVOLOG FLEXPEN, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY PROMINENT FEATURES, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY DIGITAL ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY ERGONOMIC DESIGN, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY USER ACCESSIBILITY, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY ARTHRITIS SUFFERS, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY VISUALLY IMPAIRED USERS, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN TYPES, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY ANALOG INSULIN, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY HUMAN INSULIN, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY TYPE 1 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY TYPE 2 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 184. CANADA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 185. CANADA DIABETES INJECTION PENS MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 186. CANADA DIABETES INJECTION PENS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 187. CANADA DIABETES INJECTION PENS MARKET SIZE, BY TYPE OF INJECTION PEN, 2018-2030 (USD MILLION)
TABLE 188. CANADA DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE PENS, 2018-2030 (USD MILLION)
TABLE 189. CANADA DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE PENS, 2018-2030 (USD MILLION)
TABLE 190. CANADA DIABETES INJECTION PENS MARKET SIZE, BY MODES OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 191. CANADA DIABETES INJECTION PENS MARKET SIZE, BY BASAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 192. CANADA DIABETES INJECTION PENS MARKET SIZE, BY BOLUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 193. CANADA DIABETES INJECTION PENS MARKET SIZE, BY MIXED DELIVERY, 2018-2030 (USD MILLION)
TABLE 194. CANADA DIABETES INJECTION PENS MARKET SIZE, BY THERAPEUTIC PRODUCT BRANDS, 2018-2030 (USD MILLION)
TABLE 195. CANADA DIABETES INJECTION PENS MARKET SIZE, BY HUMALOG KWIKPEN, 2018-2030 (USD MILLION)
TABLE 196. CANADA DIABETES INJECTION PENS MARKET SIZE, BY LEVEMIR FLEXPEN, 2018-2030 (USD MILLION)
TABLE 197. CANADA DIABETES INJECTION PENS MARKET SIZE, BY NOVOLOG FLEXPEN, 2018-2030 (USD MILLION)
TABLE 198. CANADA DIABETES INJECTION PENS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 199. CANADA DIABETES INJECTION PENS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 200. CANADA DIABETES INJECTION PENS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 201. CANADA DIABETES INJECTION PENS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 202. CANADA DIABETES INJECTION PENS MARKET SIZE, BY PROMINENT FEATURES, 2018-2030 (USD MILLION)
TABLE 203. CANADA DIABETES INJECTION PENS MARKET SIZE, BY DIGITAL ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 204. CANADA DIABETES INJECTION PENS MARKET SIZE, BY ERGONOMIC DESIGN, 2018-2030 (USD MILLION)
TABLE 205. CANADA DIABETES INJECTION PENS MARKET SIZE, BY USER ACCESSIBILITY, 2018-2030 (USD MILLION)
TABLE 206. CANADA DIABETES INJECTION PENS MARKET SIZE, BY ARTHRITIS SUFFERS, 2018-2030 (USD MILLION)
TABLE 207. CANADA DIABETES INJECTION PENS MARKET SIZE, BY VISUALLY IMPAIRED USERS, 2018-2030 (USD MILLION)
TABLE 208. CANADA DIABETES INJECTION PENS MARKET SIZE, BY INSULIN TYPES, 2018-2030 (USD MILLION)
TABLE 209. CANADA DIABETES INJECTION PENS MARKET SIZE, BY ANALOG INSULIN, 2018-2030 (USD MILLION)
TABLE 210. CANADA DIABETES INJECTION PENS MARKET SIZE, BY HUMAN INSULIN, 2018-2030 (USD MILLION)
TABLE 211. CANADA DIABETES INJECTION PENS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 212. CANADA DIABETES INJECTION PENS MARKET SIZE, BY TYPE 1 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 213. CANADA DIABETES INJECTION PENS MARKET SIZE, BY TYPE 2 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 214. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 215. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 216. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 217. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY TYPE OF INJECTION PEN, 2018-2030 (USD MILLION)
TABLE 218. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE PENS, 2018-2030 (USD MILLION)
TABLE 219. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE PENS, 2018-2030 (USD MILLION)
TABLE 220. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY MODES OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 221. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY BASAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 222. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY BOLUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 223. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY MIXED DELIVERY, 2018-2030 (USD MILLION)
TABLE 224. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY THERAPEUTIC PRODUCT BRANDS, 2018-2030 (USD MILLION)
TABLE 225. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY HUMALOG KWIKPEN, 2018-2030 (USD MILLION)
TABLE 226. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY LEVEMIR FLEXPEN, 2018-2030 (USD MILLION)
TABLE 227. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY NOVOLOG FLEXPEN, 2018-2030 (USD MILLION)
TABLE 228. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 229. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 230. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 231. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 232. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY PROMINENT FEATURES, 2018-2030 (USD MILLION)
TABLE 233. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY DIGITAL ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 234. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY ERGONOMIC DESIGN, 2018-2030 (USD MILLION)
TABLE 235. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY USER ACCESSIBILITY, 2018-2030 (USD MILLION)
TABLE 236. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY ARTHRITIS SUFFERS, 2018-2030 (USD MILLION)
TABLE 237. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY VISUALLY IMPAIRED USERS, 2018-2030 (USD MILLION)
TABLE 238. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY INSULIN TYPES, 2018-2030 (USD MILLION)
TABLE 239. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY ANALOG INSULIN, 2018-2030 (USD MILLION)
TABLE 240. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY HUMAN INSULIN, 2018-2030 (USD MILLION)
TABLE 241. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 242. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY TYPE 1 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 243. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY TYPE 2 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 244. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 245. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 246. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 247. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY TYPE OF INJECTION PEN, 2018-2030 (USD MILLION)
TABLE 248. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE PENS, 2018-2030 (USD MILLION)
TABLE 249. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE PENS, 2018-2030 (USD MILLION)
TABLE 250. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY MODES OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 251. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY BASAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 252. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY BOLUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 253. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY MIXED DELIVERY, 2018-2030 (USD MILLION)
TABLE 254. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY THERAPEUTIC PRODUCT BRANDS, 2018-2030 (USD MILLION)
TABLE 255. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY HUMALOG KWIKPEN, 2018-2030 (USD MILLION)
TABLE 256. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY LEVEMIR FLEXPEN, 2018-2030 (USD MILLION)
TABLE 257. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY NOVOLOG FLEXPEN, 2018-2030 (USD MILLION)
TABLE 258. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 259. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 260. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 261. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 262. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY PROMINENT FEATURES, 2018-2030 (USD MILLION)
TABLE 263. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY DIGITAL ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 264. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY ERGONOMIC DESIGN, 2018-2030 (USD MILLION)
TABLE 265. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY USER ACCESSIBILITY, 2018-2030 (USD MILLION)
TABLE 266. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY ARTHRITIS SUFFERS, 2018-2030 (USD MILLION)
TABLE 267. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY VISUALLY IMPAIRED USERS, 2018-2030 (USD MILLION)
TABLE 268. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY INSULIN TYPES, 2018-2030 (USD MILLION)
TABLE 269. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY ANALOG INSULIN, 2018-2030 (USD MILLION)
TABLE 270. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY HUMAN INSULIN, 2018-2030 (USD MILLION)
TABLE 271. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 272. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY TYPE 1 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 273. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY TYPE 2 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 274. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY TYPE OF INJECTION PEN, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE PENS, 2018-2030 (USD MILLION)
TABLE 280. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE PENS, 2018-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY MODES OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 282. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY BASAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 283. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY BOLUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 284. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY MIXED DELIVERY, 2018-2030 (USD MILLION)
TABLE 285. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY THERAPEUTIC PRODUCT BRANDS, 2018-2030 (USD MILLION)
TABLE 286. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY HUMALOG KWIKPEN, 2018-2030 (USD MILLION)
TABLE 287. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY LEVEMIR FLEXPEN, 2018-2030 (USD MILLION)
TABLE 288. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY NOVOLOG FLEXPEN, 2018-2030 (USD MILLION)
TABLE 289. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 290. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY ADULT PATIENTS, 2018-2030 (USD MILLION)
TABLE 291. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY GERIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 292. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY PEDIATRIC PATIENTS, 2018-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY PROMINENT FEATURES, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY DIGITAL ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY ERGONOMIC DESIGN, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY USER ACCESSIBILITY, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY ARTHRITIS SUFFERS, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY VISUALLY IMPAIRED USERS, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY INSULIN TYPES, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY ANALOG INSULIN, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY HUMAN INSULIN, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY TYPE 1 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY TYPE 2 DIABETES PATIENTS, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 309. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY TYPE OF INJECTION PEN, 2018-2030 (USD MILLION)
TABLE 310. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE PENS, 2018-2030 (USD MILLION)
TABLE 311. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE PENS, 2018-2030 (USD MILLION)
TABLE 312. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY MODES OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 313. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY BASAL DELIVERY, 2018-2030 (USD MILLION)
TABLE 314. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY BOLUS DELIVERY, 2018-2030 (USD MILLION)
TABLE 315. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY MIXED DELIVERY, 2018-2030 (USD MILLION)
TABLE 316. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY THERAPEUTIC PRODUCT BRANDS, 2018-2030 (USD MILLION)
TABLE 317. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY HUMALOG KWIKPEN, 2018-2030 (USD MILLION)
TABLE 318. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY LEVEMIR FLEXPEN, 2018-2030 (USD M

Companies Mentioned

  • AstraZeneca PLC
  • Becton, Dickinson, and Company
  • Biocon Limited
  • Dexcom Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Haselmeier GmbH
  • Jiangsu Delfu Medical Device Co., Ltd.
  • Medtronic PLC
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Owen Mumford Limited
  • Pfizer Inc.
  • Sanofi S.A.
  • Ypsomed Holding AG

Methodology

Loading
LOADING...

Related Topics

Related Reports

Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, Obesity, Fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030 - Product Image

Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, Obesity, Fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030

  • Report
  • 243 Pages
  • Global
From
Injection Pen Market by Type, Application, End User, Indication - Global Forecast 2025-2030 - Product Image

Injection Pen Market by Type, Application, End User, Indication - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Diabetes Injection Pens - Global Strategic Business Report - Product Image

Diabetes Injection Pens - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Injection Pen Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Application (Osteoporosis, Diabetes, Anaphylaxis), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Injection Pen Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Application (Osteoporosis, Diabetes, Anaphylaxis), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 170 Pages
  • Global
From
Insulin Injection Pen & Needle Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Image

Insulin Injection Pen & Needle Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • 88 Pages
  • Global
From

About the Insulin Pen Injector Market

The Insulin Pen Injector market is a subset of the Infusions and Injectables market. Insulin Pen Injectors are used to deliver insulin to patients with diabetes. These devices are designed to be easy to use and provide accurate dosing. They are often preferred over traditional syringes due to their convenience and portability. Insulin Pen Injectors are available in both disposable and reusable models. The reusable models are typically more expensive but offer more flexibility in terms of dosing and delivery. The Insulin Pen Injector market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Novo Nordisk, Eli Lilly, Sanofi, and Becton Dickinson. Other companies such as Ypsomed, Owen Mumford, and Insulet also offer insulin pen injectors. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.